Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q1 2015 · 10-Q
Revenue$121.00K$121.00K+121.0% vs Q1 2014 Net Income-$364.01K-$364.01KN/M vs Q1 2014 EPS Diluted-$0.01-$0.01— vs Q1 2014 Gross Profit$95,944+105.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flow-$116,974N/M Free Cash Flowderived-$117,692— Margins · derivedGross margin79.3%−6.1 pt vs Q1 2014
Operating margin-242.0%+174.3 pt vs Q1 2014
Net margin-300.8%+77.1 pt vs Q1 2014
ended Mar 31, 2015 · filed May 19, 2015 · 49 d after period end